Office of Professional Education


Developing the next generation of physician-scientists: a research and career mentorship opportunity for fellows and early career faculty.

October 14-17, 2021 • Denver, CO

If you need additional information, please contact Mandy Comeau of National Jewish Health, at 303.728.6585 or comeaum@njhealth.org

 


This unique educational opportunity is designed for pulmonary, allergy and immunology fellows and junior faculty who are in their first few years in an academic role. Thirty young investigators whose Basic Science Research or Clinical Research abstracts are selected will be invited to present their research at the Forum where a panel of expert faculty will evaluate their presentations and score them on specified criteria. Selected winners will be awarded a grant to support their future research endeavors in respiratory medicine.Throughout the Forum, attendees will enjoy opportunities to meet and interact with expert faculty and peer researchers. 

► View or download the 2021 Call For Research Abstracts Brochure (PDF) here

►​ For a downloadable one-page announcement about the Forum in 2021, click here (PDF).

► Congratulations to our Research Award winners and to all who were selected to present at the16th Annual Respiratory Disease Young Investigators' Forum held online October 8-10, 2020. Read more.

► For a  downloadable newsletter that recaps the 2020 Forum and provides insight on how it impacts the future of physician-scientists, click here (PDF).


ATS Scholar Publishes Study on Impact of Forum

Learn how the Forum impacts the future of physician-scientists in this study published in ATS Scholar.  View the article.


Please click on the following topics for more information:

Description

Learn why this Forum exists and the impact is has on the future of research in medicine.

 

Activity Information and Agenda

See the tentative schedule of events based on last year's forum.

 

Eligibility and Selection Process

Understand who is eligible to submit abstracts and how judges make their selections.

 

Abstract Submission and Notification Process

Rules for preparing your submission and the timeline for notification.

Faculty Judges and Research Advisors

Meet the Faculty who will serve at the 2021 Forum.

A Review of Previous Forums

View photos, videos and recaps from 2017 through 2020.


In this video, Barry Make, MD, shares about his role as a research advisor at the Forum and how the rehearsal sessions help the investigators prepare for their presentations and for their careers.​


 

Description

The Seventeenth Annual Respiratory Disease Young Investigators’ Forum

This Forum is a unique educational opportunity designed for pulmonary, allergy and immunology fellows and junior faculty who are in their first few years in an academic role.

The goals of this program are to facilitate mentoring relationships with expert faculty in respiratory medicine, expand connections to peer investigators, improve the quality of scientific investigation and enhance the communication and presentation of associated research findings.

Throughout the Forum, attendees will enjoy opportunities to meet and interact with expert faculty and peer researchers. Opportunities to meet with specific expert faculty during scheduled meals will be available. Along with scientific presentations from the Young Investigators, expert faculty will provide several presentations over the course of the Forum on topics highly relevant to developing a career as a physician scientist.

Eligible candidates are invited to submit an abstract of their research (clinical or basic science) to a panel of expert faculty for review. Abstracts will be blinded and scored by the expert faculty. Based on these scores, the top 30 abstracts are accepted. It should be noted that the final selection of abstracts is based on the quality of the research and the number of abstracts received in each category.

At the forum, the 30 fellows will present their research in podium format and expert faculty will evaluate their presentations and score them on specified criteria. Selected winners will be awarded a grant, as outlined below, to support their future research endeavors in respiratory medicine.

This Forum has been a successful program for the past 16 years. Previous participants indicate that it is one of the best programs they have attended because of its focus on research, interaction with other young investigators, and the mentorship that is provided by world renowned experts in respiratory medicine.

As the leading respiratory hospital, National Jewish Health is committed to growing young scientists to become leaders in the research and treatment of respiratory diseases, and is excited to be sponsoring this important forum.

Back to Top


 

Activity Information and Agenda

Target Audience:

US-based Fellows (MDs, DOs) currently enrolled in a pediatric, pulmonary, allergy and immunology fellowship program and/or physicians who have transitioned from fellowship to an academic role in the past 2 years and are conducting research on airway diseases, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease and others, in either pediatric or adult  populations. Recognizing the apt attention the current pandemic requires across all healthcare organizations, we also welcome research on COVID-19 to be submitted in this Call for Abstracts.

All attendees will be required to attend all program activities. 

 

Presentation Format: 

Young Investigator presentations will be podium format with 8 minutes dedicated to the formal presentation followed by 7 minutes of questions and answers from expert faculty and peer investigators. 

 

2021 Tentative Agenda for Denver, CO Location:

Thursday, October 14, 2021
11:00 – 5:00 PM (MST) Rehearsal Sessions
6:30 – 8:30 PM      Welcome Reception/Dinner
   
Friday, October 15, 2021
8:00 – 3:40 PM  Breakfast
  Young Investigators’ Presentations
  Expert Faculty Career-Based Presentations
  Meet-the-Professor Lunch
6:30 – 8:30 PM      Dinner
   
Saturday, October 16, 2021
8:00 – 3:40 PM  Breakfast
  Young Investigators’ Presentations
  Expert Faculty Career-Based Presentations
  Meet-the-Professor Lunch
6:30 – 8:30 PM      Awards Dinner


Science Never Stops – We are proceeding with plans to hold the 2021 Forum in-person in Denver, CO, adhering to guidelines set forth by the CDC. In the event that a live conference is not possible in October, virtual options are under consideration.

Learning Objectives:

  1. Discuss new and emerging areas of respiratory research that offer new inroads to effective therapies and treatment

  2. Identify best practices for designing a research study and multidisciplinary research team that may improve on current approaches to respiratory research

  3. Evaluate the strengths and weaknesses of peer research presentations

  4. Incorporate peer/expert faculty feedback effectively to enhance research presentations

  5. Discuss key strategies for career development as a physician scientist

  6. Describe comprehensive process for securing grant support for research

 

Credit Designation and Compliance:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education by National Jewish Health. National Jewish Health is accredited by the ACCME to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Contact:

For additional information, please contact Mandy Comeau of National Jewish Health, at 303.728.6585 or comeaum@njhealth.org

Back to Top


 

Eligibility and Selection Process

Abstract Submission Deadline:

All abstracts must be received by June 21, 2021.

 

Eligibility:

  • US-based Fellows (MDs, DOs) currently enrolled in a pediatric, pulmonary, allergy and immunology fellowship program and/or physicians who have transitioned from fellowship to an academic role in the past 2 years and are conducting basic science or clinical research on airway diseases, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease, allergic rhinitis, genetics of airway diseases, sleep disorders, or bronchiectasis, in either pediatric or adult  populations. Recognizing the apt attention the current pandemic requires across all healthcare organizations, we also welcome research on COVID-19 to be submitted in this Call for Abstracts.

  • Fellows enrolled in basic science or clinical research programs during the 2020-2021 academic year. Young investigators transitioning to initial faculty positions in the last 2 years are especially encouraged to participate.

  • PhD-only research Fellows are not eligible.

  • Candidates must be based in the United States (training must be completed at a US-based institution).

 

Abstract Policies and Procedures:

All work must be unpublished original research in an area related to lung diseases. Publication as an abstract alone does not preclude eligibility; however, an abstract will not be accepted if it has been published as an article before October 1, 2021. Abstracts/papers to be presented at future medical meetings are eligible for submission. Only 1 abstract submission of original work will be accepted. 

All accepted abstracts will be published in a program workbook. The publication of this workbook will not preclude publication or presentation elsewhere. 

 

Selection Process:

Expert faculty will review all abstracts and 30 finalists will be selected based on the following criteria:

  1. Scientific importance – will this research make a difference in diagnosis, treatment or quality of patient care?

  2. Quality of research – is the hypothesis feasible and will the stated methodology enable this research to be completed in a meaningful way?

  3. Enhance knowledge – will the research improve our knowledge about the disease or treatment?

  4. Does the research answer a question that needs to be answered or provide new findings that may change the way we diagnose or treat a condition?

  5. Overall presentation of abstract – Is the abstract informative and thoughtfully written; does it outline the question to be addressed; and is the research proposed able to provide an answer?

 

Awards:

An awards ceremony will be held on Saturday evening, October 17, 2021, at which the award winners in each of the 2 categories (basic science and clinical) will be announced.

Back to Top


 

Abstract Submission and Notification Process

Instructions for Abstract Preparation and Submission:

1. Identification: Abstracts that do not have complete identification information may not be accepted.

Your submission must include the following information:

  • Full Name, degree(s)

  • Mailing address (PO Boxes will not be accepted)

  • Daytime telephone, fax, pager, e-mail address,

  • Current institution

  • Previous institution (where research was conducted, if applicable)

  • Year of fellowship (1, 2, 3) or year 1 or 2 as faculty

  • Category of research: basic science or clinical research

2. Format:

Title and Author:
Abstracts should consist of a brief title (bold) descriptive of the research and include first and last names and degrees of all authors with the presenting author’s name underlined. Also include the name and location of the institution where the research was completed. Please do not identify authors in the body of the abstract.

Text:
Abstract text must be 500 words or fewer. Sans serif font (such as Arial or Helvetica) is preferred. Please do not use font sizes smaller than 10 point.​

Figures and Tables:
Please make sure all figures are high resolution (at least 300 dpi). No more than a total of 4 figures and/or tables per submission are permitted. Please limit figures to 1 graph or image each (ie, no multiple-part figures). All figures will be printed in black and white. Legends should be included and are not included in the 500-word limit; figures should be embedded in the abstract file and not included as separate e-mail attachments.

Content:
Organize the body of the abstract in the following manner:

  1. Disclosure of relevant financial relationships (not included in word count).

  2. A sentence stating the purpose of the study, unless stated in the title

  3. A brief statement of methods, if pertinent.

  4. A summary of results

  5. A statement of the conclusions reached. It is not satisfactory to state “the results will be discussed.”

 

Notification:

  • Abstract Receipt: Notification of abstract receipt will be provided to you via e-mail.

  • Abstract Acceptance: Notification of abstract acceptance or rejection will be provided to you via e-mail in July 2021.

Back to Top


 

2021 Program Faculty:

Barry J. Make, MD (Program Co-Chair)
Professor of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Co-Director, COPD Program
Director, Pulmonary Rehabilitation and Respiratory Care 
National Jewish Health
Denver, CO
   
Jennifer Taylor-Cousar, MD, MSCS, ATSF  (Program Co-Chair)
President-elect, Medical Staff
Medical Director, Clinical Research Services
Co-Director, Adult Cystic Fibrosis Program
Director, Cystic Fibrosis Therapeutics Development Center Adult Program
Professor of Medicine and Pediatrics
Division of Pulmonary, Critical Care & Sleep Medicine
Division of Pediatric Pulmonary Medicine
National Jewish Health
Denver, CO
   
Neil Aggarwal, MD Neil Aggarwal, MD
Chief, Lung Biology and Disease Branch
Division of Lung Diseases
National Heart, Lung, and Blood Institute, NIH
Bethesda, MA​
   
Mario Castro, MD, MPH
Division Chief, Pulmonary, Critical Care and Sleep Medicine
Vice Chair for Clinical and Translational Research
Director, Frontiers Clinical and Translational Science Institute at the University of Kansas
Director, Rainbow Clinical Trials Science Unit
The University of Kansas School of Medicine
Kansas City, KS
   
Harold R. Collard, MD
Associate Vice Chancellor of Clinical Research 
Professor in Residence in the Division of Pulmonary and Critical Care Medicine
Department of Medicine 
Director of the UCSF Clinical and Translational Science Institute (CTSI)
University of California, San Francisco
San Francisco, CA
   
Marie Egan, MD
Professor of Pediatrics (Respiratory) and of Cellular And Molecular Physiology
Director, Cystic Fibrosis Center
Vice Chair for Research, Department of Pediatrics
Yale School of Medicine
New Haven, CT
   
Ravi Kalhan, MD, MS
Professor of Medicine and Preventive Medicine
Director, Asthma and COPD Program
Associate Chief – Clinical & Translational Research
Division of Pulmonary and Critical Care Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

Co-Director, Center for Education and Career Development
Northwestern University Clinical and Translational Sciences (NUCATS) Institute
   
Elizabeth Matsui, MD, MHS
Professor, Department of Population Health and Department of Pediatrics
Associate Chair of Research, Department of Population Health
Associate Director, Health Transformation Research Institute
University of Texas at Austin Dell Medical School
Austin, TX
   
Susanna A. McColley, MD
Scientific Director, Interdisciplinary Research Partnerships
Stanley Manne Children's Research Institute
Associate Director for Child Health and Director, TL1 Program
Northwestern University Clinical and Translational Sciences Institute
Editor-in-Chief, Pediatric Pulmonology
Attending Physician, Pulmonary and Sleep Medicine
Ann & Robert H. Lurie Children's Hospital of Chicago
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL 
   

Research Advisors:

Jane E. Gross, MD, PhD
Assistant Professor, Department of Pediatrics and Medicine
Divisions of Pediatric Pulmonary Medicine and Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, CO
   
Victor E. Ortega, MD, PhD, ATSF
Associate Professor
Department of Internal Medicine, 
Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases 
Wake Forest School of Medicine
Winston-Salem, NC
   
Deepika Polineni, MD, MPH
Assistant Professor
Pulmonary, Critical Care and Sleep Medicine
University of Kansas Medical Center
Kansas City, KS


Back to Top


 

A Review of Previous Forums

Back to Top


 

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.